A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer

Lessons Learned Coadministration of S‐1 and paclitaxel in elderly patients with advanced non‐small cell lung cancer showed favorable efficacy. Coadministration of S‐1 and paclitaxel in elderly patients with advanced non‐small lung cancer showed tolerable toxicity. Background Although monotherapy wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2019-04, Vol.24 (4), p.459-e131
Hauptverfasser:	Yoshimura, Akihiro, Chihara, Yusuke, Date, Koji, Tamiya, Nobuyo, Takemura, Yoshizumi, Imabayashi, Tatsuya, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma of Lung - drug therapy Adenocarcinoma of Lung - pathology Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Clinical Trial Results Drug Combinations Female Follow-Up Studies Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Oxonic Acid - administration & dosage Paclitaxel - administration & dosage Prognosis Survival Rate Tegafur - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!